Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RENALIS: Linagliptin vs Glimepiride in T2DM
NCT02106104Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Amsterdam University Medical Center. Started Mar 2014; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02106104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02106104.